Catalyst Pharmaceuticals Inc (CPRX) support and resistance · P/E 18, rev $491.7M
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
This page maps Catalyst Pharmaceuticals Inc (CPRX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CPRX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CPRX quote page for the session range and the stock page for the full model.
Not investment advice.